Comedogenesis: some new aetiological, clinical and therapeutic strategies
Hypercornification is an early feature of acne and precedes inflammation. It is associated with ductal hyperproliferation and there are many controlling factors such as androgens, retinoids and cytokines. Cycling of normal follicles and of comedones may explain the natural resolution of comedones an...
Saved in:
Published in: | British journal of dermatology (1951) Vol. 142; no. 6; pp. 1084 - 1091 |
---|---|
Main Authors: | , , , |
Format: | Journal Article Conference Proceeding |
Language: | English |
Published: |
Oxford, UK
Blackwell Science Ltd
01-06-2000
Blackwell Oxford University Press |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Hypercornification is an early feature of acne and precedes inflammation. It is associated with ductal hyperproliferation and there are many controlling factors such as androgens, retinoids and cytokines. Cycling of normal follicles and of comedones may explain the natural resolution of comedones and, in the longer term, resolution of the disease itself. There is a need to tailor treatment according to comedonal type. Suboptimal therapy can often result from inappropriate assessments of comedones, especially microcomedones, missed comedones, sandpaper comedones, submarine comedones and macrocomedones. Macrocomedones can produce devastating acne flares, particularly if patients are inappropriately prescribed oral isotretinoin. Gentle cautery under topical local anaesthesia is a useful therapy in the treatment of such lesions. The newer retinoids and new formulations of all‐trans‐retinoic acid show a better benefit/risk ratio. Evidence‐based studies are required to allow adequate comparisons. |
---|---|
Bibliography: | istex:9F60C4638DDD8745061FF6375544E48D127C61DE ark:/67375/WNG-LXNV91JD-R ArticleID:BJD3531 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 0007-0963 1365-2133 |
DOI: | 10.1046/j.1365-2133.2000.03531.x |